Loading...
Back
NCN
NCN
NUCANA PLC
(NCNA)
2026 6-K
Follow
Summary
Share
Summary
Financial Results Update
19 Mar '26
Management Change
6 Jan '26
Leadership Change
17 Dec '25
Clinical Data Announcement
10 Dec '25
Q3 2025 Results
13 Nov '25
Patent Announcement
5 Nov '25
Clinical Data Release
14 Oct '25
Nasdaq Compliance
5 Sep '25
Presentation Announcement
3 Sep '25
Q2 Financial Results
20 Aug '25
ADS Ratio Change
1 Aug '25
Warrant Cancellation
21 Jul '25
ADS Ratio Change
11 Jul '25
Nasdaq Delisting Notice
9 Jul '25
Sales Agreement Signed
30 Jun '25
Warrant Agreements Update
27 Jun '25
Nasdaq Compliance Alert
20 Jun '25
Management Changes
18 Jun '25
Annual Report Released
5 Jun '25
Financial Results Report
2 Jun '25
General Meeting Passed
23 Apr '25
Financial Results Update
20 Mar '25
General Meeting Notice
18 Mar '25
CFO Departure
10 Feb '25
Third Quarter Results
25 Nov '24
Clinical Data Release
12 Nov '24
Funding Update
30 Sep '24
New Patent Announcement
26 Sep '24
Data Presentation
16 Sep '24
Study Discontinued
29 Aug '24
Q2 Financial Results
15 Aug '24
Annual Meeting Summary
18 Jun '24
Q1 Financial Results
16 May '24
Annual Report Announcement
13 May '24
Compliance Regained
1 May '24
ADS Ratio Change
16 Apr '24
Cancer Research Presentation
9 Apr '24
ADS Ratio Change
27 Mar '24
Financial Results Update
20 Mar '24
External Links:
SEC
On March 19, 2026, NuCana plc released its financial results for the year ending December 31, 2025, along with updates on its clinical programs.
AI Assistant
Close
NUCANA PLC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.